K. Dahl, M. Schou, O. Rahman, C. Halldin
SHORT COMMUNICATION
B. Långström, J. Org. Chem. 2003, 68, 3558–3562; d) O. It-
senko, T. Kihlberg, B. Långström, J. Org. Chem. 2004, 69,
4356–4360; e) H. Doi, J. Barletta, M. Suzuki, R. Noyori, Y.
Watanabe, B. Långström, Org. Biomol. Chem. 2004, 2, 3063–
3066; f) J. Eriksson, O. Åberg, B. Långström, Eur. J. Org.
Chem. 2007, 455–461; g) G. Buscemi, P. W. Miller, S. Kealey,
A. D. Gee, N. J. Long, J. Passchier, R. Vilar, Org. Biomol.
Chem. 2011, 9, 3499–3503; h) P. W. Miller, H. Audrain, D.
Bender, A. J. deMello, A. D. Gee, N. J. Long, R. Vilar, Chem.
Eur. J. 2011, 17, 460–463.
Experimental Section
General Procedure for the Microwave-Enhanced [11C]Carbonylation
Reaction: 11CO2 was reduced online to 11CO by using a pre-heated
quartz column (850 °C) charged with Mo-powder. Unreacted
11CO2 was subsequently removed by an ascarite trap and the 11CO
was concentrated on a silica gel trap immersed in liquid nitrogen.
Upon complete entrapment, the trap was heated to release the
11CO into a vial (4 mL) containing the coupling reagents (aryl hal-
ide, Pd-source, ligand and amine dissolved in appropriate solvent)
equipped with a rubber septum. The sealed reaction vessel was
manually transferred to the microwave cavity and heated at the
desired temperature for 2–5 min, after which the vial was cooled to
room temp. The radioactivity was measured before and after the
vial was purged with nitrogen. Radiochemical purity (RCP) of the
crude reaction mixture was established with radio-HPLC. For a
more detailed description of the reaction procedure, see the Sup-
porting Information.
[4] K. Dahl, M. Schou, N. Amini, C. Halldin, Eur. J. Org. Chem.
2013, 1228.
[5] a) R. Gedye, F. Smith, K. Westaway, H. Ali, L. Baldisera, L.
Laberge, J. Rousell, Tetrahedron Lett. 1986, 27, 279–282; b)
C. O. Kappe, Angew. Chem. 2004, 116, 6408; Angew. Chem. Int.
Ed. 2004, 43, 6250.
[6] D. R. Hwang, S. M. Moerlein, L. Lang, M. J. Welch, J. Chem.
Soc., Chem. Commun. 1987, 1799.
[7] a) N. Elander, J. R. Jones, S. Y. Lu, S. Stone-Elander, Chem.
Soc. Rev. 2000, 29, 239; b) S. Stone-Elander, N. Elander, J.
Labelled Compd. Radiopharm. 2002, 45, 715; c) N. Lazarova,
F. G. Simeon, J. L. Musachio, S. Y. Lu, V. W. Pike, J. Labelled
Compd. Radiopharm. 2007, 50, 463–465.
[8] a) C. M. Kormos, N. E. Leadbeater, Synlett 2006, 1663; b)
C. M. Kormos, N. E. Leadbeater, Org. Biomol. Chem. 2007, 5,
65; c) J. Salvadori, E. Balducci, S. Zaza, E. Petricci, M. Taddei,
J. Org. Chem. 2009, 75, 1841; d) E. Awuah, A. Capretta, Org.
Lett. 2009, 11, 3210; e) B. Roberts, D. Liptrot, L. Alcaraz, Org.
Lett. 2010, 12, 1264; f) D. Liptrot, L. Alcaraz, B. Roberts, Adv.
Synth. Catal. 2010, 352, 2183.
[9] a) C. Aubert, C. Perrio-Huard, M. C. Lasne, J. Chem. Soc. Per-
kin Trans. 1 1997, 2837–2842; b) C. Perrio-Huard, C. Aubert,
M. C. Lasne, J. Chem. Soc. Perkin Trans. 1 2000, 311–316; c)
M. Matarrese, F. Sudati, D. Soloviev, S. Todde, E. A. Turolla,
M. G. Kienle, F. Fazio, Applied Radiation Isotopes 2002, 57,
675–679; d) S. Y. Lu, J. Hong, V. W. Pike, J. Labelled Compd.
Radiopharm. 2003, 46, 1249–1259.
Supporting Information (see footnote on the first page of this arti-
cle): General methods, experimental procedures, and radio-HPLC
chromatograms.
Acknowledgments
This research was supported by GEMS PET Systems AB (GE
Healthcare). The authors thank all members of the PET group at
Karolinska Institutet for their support.
[1] M. P. Phelps, Neurochem. Res. 1991, 16, 929–940.
[2] P. W. Miller, N. J. Long, R. Vilar, A. D. Gee, Angew. Chem.
2008, 120, 9136; Angew. Chem. Int. Ed. 2008, 47, 8998.
[3] a) B. Långström, O. Itsenko, O. Rahman, J. Labelled Compd.
Radiopharm. 2007, 50, 794; b) T. Kihlberg, B. Långström, J.
Org. Chem. 1999, 64, 9201–9205; c) O. Rahman, T. Kihlberg,
Received: October 22, 2013
Published Online: November 22, 2013
310
www.eurjoc.org
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2014, 307–310